3Iiaba K. Dendritic cell sasantigen-presenting cells in vivo [ J ]. Immunol Cell Biol, 1997,75 (2) : 206-208.
4Cchapuis F, Rosenzwajg M, Yagello M, et al. Diff&entiation of human dendritic cells frommonocytes in vitro[J]. Eur J Immunol, 1997,27(2) : 431-441.
5Beckebaum S, Cicinnati VR, Dworacki G, et al. Reduction in the culating MDC/PDC ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection [ J ]. Clin Immunol, 2002, 104 ( 2 ) : 138- 150.
6Kunitani H, Shimizu Y, Murata H, et al. Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases[J] .J Hepatol,20(Y2,36(6) :734-741.
7Kurose K, Akbar SMF, Yamamoto K, et al. Production of antibody to hepatitis B surface antigen (anti-HBs) by mufine hepatitis B virus carriers:neonatal tolerance versus antigen presentation by dendritic cells [J] .Immunology, 1997,92(4) :494-500.
8Carreno V, Zeuzem S, Hopf U, et al. A phaseⅠ/Ⅱ study of recombinan human interleukin-12 in patients with chronic hepatitisB[J].J Hepatology,2000,32(2) :317-324.
9Kakumu S, Ito S, Ishikawa T, et al. Decreased function of peripheral blood dendritic cells in patients with hepatocelluar carcinoma with hepatitis B and C virus infection[J]. J Gastroenterol Hepatol,2000, 15 (4) :431-436.
10Ninomiya T,Akbar SMF, Masumoto T, et al. Dendritic ceils with imatur ephenotype and defective function in the peripheral blood from patients with hepato cellular carcinoma[J] .J Hepatol, 1999,31(2) :323-331.
